CClinicalTrials.gg
RecruitingNCT07456904OnTRACUpdated Jun 18, 2026

Outcomes of Health Care Transition for AYA With a Cancer Predisposition

An observational study in Genetic Predisposition, sponsored by St. Jude Children's Research Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-18.

Sponsored by St. Jude Children's Research Hospital · Observational

From the registry’s dates

  • Started Jun 2026; still recruiting 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
56
Ages
18 Years and older
Sex
All
01

Study summary

This observational study evaluates whether adolescents and young adults (AYAs) with a cancer predisposition syndrome (CPS) establish and maintain adult health care and continue CPS-specific cancer surveillance after graduating from pediatric care at St. Jude Children's Research Hospital (SJCRH). Participants will complete a Readiness Assessment and periodic surveys over 8 years post-graduation.

Primary Objectives

  • To evaluate whether adolescents and young adults (AYAs) with a cancer predisposition syndrome (CPS) report they have established care with adult health care providers and pursue CPS-specific cancer surveillance within 1-year post-graduation from SJCRH.
  • To evaluate whether AYAs with CPS report they maintain care with adult health care providers and continue CPS-specific cancer surveillance 3 years post-graduation from SJCRH.

Exploratory Objectives:

  • To evaluate whether AYAs with CPS report they continue to maintain care with adult health care providers and complete CPS-specific cancer surveillance longitudinally 5 years and 8 years post-graduation from St. Jude Children's Research Hospital (SJCRH).
  • To examine clinical correlates of establishing care with adult providers and initiating CPS-specific cancer surveillance post-graduation from SJCRH.
  • To identify the tumors diagnosed in AYAs with CPS after they graduate from SJCRH and determine how these tumors were identified (i.e., through specific surveillance tests or based on symptoms).
  • To identify barriers and facilitators AYAs face when establishing and maintaining adult health care and pursuing CPS-specific cancer surveillance.
Read the detailed description

The OnTRAC study investigates the outcomes of AYAs with CPS following their transition from pediatric to adult health care. The study aims to assess whether participants establish care with adult providers and adhere to recommended cancer surveillance protocols. Participants will complete a Readiness Assessment one month post-graduation and electronic Transition Outcomes Surveys at 1, 3, 5, and 8 years. These surveys will evaluate health care engagement, cancer screening adherence, barriers and facilitators to care, and psychosocial experiences. The study will also explore clinical and demographic correlates of successful transition and surveillance adherence.

02

Conditions studied

  • Genetic Predisposition

Keywords

  • Genetic cancer risk
  • Cancer predisposition
  • Health care transition
  • Adolescent and young adult oncology
03

In context

Genetic Predisposition to Disease

235 studies on the registry are indexed under Genetic Predisposition to Disease; 94 are open to participants now.

This study's planned enrollment of 56 is below the median of 400 across 154 observational studies indexed under Genetic Predisposition to Disease.

Browse Genetic Predisposition to Disease studies →

Lead sponsor

St. Jude Children's Research Hospital is the lead sponsor of 434 studies on the registry; 99 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 35 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All participants who meet eligibility criteria and consent to enrollment on the study

Inclusion criteria

  • Participants are ≥18 years of age
  • Participants with a molecular or clinical diagnosis of a Cancer Predisposition Syndrome (CPS) who are graduating or have graduated from SJCRH.
  • Participants who were a patient of the SJCRH Cancer Predisposition Clinic for at least 3 years before graduating from SJCRH
  • Participants who require cancer/tumor surveillance within 1 year after graduation from SJCRH. Required cancer/tumor surveillance in adulthood is defined as having a CPS with expert guidelines recommending cancer/tumor surveillance in adulthood
  • Participants fluent in English.

Exclusion criteria

Exclusion Criteria:

  • Participants who are not their own legal medical decision-maker.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
56 participants (estimated)
Patient registry
No

Groups and cohorts

  • Transition Cohort

    AYAs with CPS who have graduated from SJCRH and are followed longitudinally through surveys and assessments to evaluate health care transition outcomes.

    Behavioral: Readiness Assessment · Behavioral: Transition Outcomes Survey A · Behavioral: Transition Outcomes Survey B

Interventions

  • BehavioralReadiness Assessment

    Electronic assessment administered 1 month post-graduation to evaluate transition preparedness.

  • BehavioralTransition Outcomes Survey A

    Administered at 1 and 3 years post-graduation to assess health care engagement and psychosocial outcomes.

  • BehavioralTransition Outcomes Survey B

    Administered at 5 and 8 years post-graduation to assess long-term outcomes and cancer surveillance adherence.

06

What researchers measure

Primary outcomes

  1. Establishment of Adult Health Care

    Proportion of Young Adults with Cancer Predisposition Syndromes Who Have an Identified Adult Medical Provider Managing Cancer Surveillance One Year Post-Pediatric Care Transition

    Time frame: Evaluated 1 year after consent from the study.

  2. Maintenance of Adult Health Care

    Proportion of Young Adults with Cancer Predisposition Syndromes Who Maintain an Identified Adult Medical Provider for Cancer Surveillance Three Years Post-Pediatric Care Transition

    Time frame: Evaluated 3 years after consent from the study.

07

Study locations

1 of 1 sites recruiting
  • St. Jude Children's Research Hospital
    Memphis, Tennessee 38105, United States
    Recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07456904
Lead sponsor
St. Jude Children's Research Hospital
Responsible party
Sponsor
First posted
Mar 9, 2026
Start date
Jun 16, 2026
Primary completion
Nov 2034 (estimated)
Completion
Nov 2037 (estimated)
Last update
Jun 18, 2026

Study contacts

Melissa R Perrino, MD
Contact
referralinfo@stjude.org
888-226-4343
Melissa R Perrino, MD
principal investigator · St. Jude Children's Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion